Vertex Pharmaceuticals Inc. buy SVB Leerink LLC
Start price
25.09.25
/
50%
€330.00
Target price
25.09.26
€388.33
Performance (%)
13.36%
Price
13.04.26
€374.10
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC currently has a performance of 13.36%. This prediction currently runs until 25.09.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.643% | -1.643% |
| iShares Core DAX® | 3,02 % | 2,20 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % |
| iShares S&P 500 | 2,64 % | 1,01 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $456.00 price target on the stock, down previously from $458.00.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€393.15
29.12.25
29.12.25
€445.67
29.12.26
29.12.26
-4.85%
13.04.26
13.04.26
